Investors on Alert as Indofarma (INAF) Prepares for Major Announcement
PT Indofarma (Persero) Tbk (INAF) has announced that it will hold an Extraordinary General Meeting of Shareholders (EGMS) for the year 2026, with the agenda focused on changes to the composition of the company’s management.
According to information disclosure from the Indonesia Stock Exchange (IDX), the meeting is scheduled to take place on Thursday, 29 October 2026, starting from 14:00 WIB.
The EGMS will be conducted electronically via the e-RUPS system provided by PT Kustodian Sentral Efek Indonesia (KSEI), specifically through the eASY.KSEI platform, which can be accessed via akses.ksei.co.id.
“The single agenda item of the meeting is the change in the company’s management composition,” the management stated on Wednesday (7/10/2026).
In its brief explanation, the company referred to its Articles of Association. Article 11, paragraph (6) stipulates that members of the Board of Directors are appointed and dismissed by the General Meeting of Shareholders (GMS). This GMS must be attended by the Series A Dual-Class Shareholders, and its decisions must be approved by said shareholders.
Members of the Board of Directors are appointed from candidates proposed by the Series A Dual-Class Shareholders, and such nominations are binding for the GMS. The same provisions apply to a GMS held to revoke or confirm the temporary dismissal of a member of the Board of
Directors.
Regarding the Board of Commissioners, Article 14, paragraph (7) of the Articles of Association states that members of the Board of Commissioners are appointed and dismissed by the GMS through a similar mechanism: the GMS must be attended by and its decisions approved by the Series A Dual-Class Shareholders, with candidates proposed by those shareholders, making the nomination binding for the GMS. These provisions also apply to a GMS held to revoke or confirm the temporary dismissal of a member of the Board of Commissioners.